PMCC Staff Publications

pmcc logo sml

 

 Here are the staff publications for November 2020.

Compiled by the Health Sciences Library (RMH, RWH, PMCC & Victorian Mental Health) 2nd December 2020.

 

1. Abo YN, Brock C, Boyce S, et al. An Infant Presenting With Fever, Abdominal Distension, Diarrhea and Vomiting. Pediatric Infectious Disease Journal 2020;39:1134-7.

2. Algwaiz G, Aljurf M, Koh M, et al. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. Biology of Blood and Marrow Transplantation 2020;26:2181-9.

3. Amann-Zalcenstein D, Tian L, Schreuder J, et al. A new lymphoid-primed progenitor marked by Dach1 downregulation identified with single cell multi-omics. Nature Immunology 2020;21:1574-84.

4. Azar WJ, Christie EL, Mitchell C, Liu DS, Au-Yeung G, Bowtell DDL. Noncanonical IL6 Signaling-Mediated Activation of YAP Regulates Cell Migration and Invasion in Ovarian Clear Cell Cancer. Cancer Research 2020;80:4960-71.

5. Baldi AJ, Clucas D, Pasricha SR. Anemia and water, sanitation, and hygiene (WASH)-is there really a link? American Journal of Clinical Nutrition 2020;112:1145-6.

6. Bedő J, Di Stefano L, Papenfuss AT. Unifying package managers, workflow engines, and containers: Computational reproducibility with BioNix. Gigascience 2020;9.

7. Cardoso F, Paluch-Shimon S, Senkus E, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Annals of Oncology 2020;31:1623-49.

8. Carr MJ, Sun J, Kroon HM, et al. Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia. Annals of Surgical Oncology 2020;27:5107-18.

9. Conduit C, de Boer RH, Lok S, et al. Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer. Asia-Pacific Journal of Clinical Oncology 2020;16:356-62.

10. Cowan AJ, Baldomero H, Atsuta Y, et al. The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study. Biology of Blood and Marrow Transplantation 2020;26:2372-7.

11. Denost Q, Solomon M, Tuech JJ, et al. International variation in managing locally advanced or recurrent rectal cancer: prospective benchmark analysis. British Journal of Surgery 2020;107:1846-54.

12. Dhont J, Harden SV, Chee LYS, Aitken K, Hanna GG, Bertholet J. Image-guided Radiotherapy to Manage Respiratory Motion: Lung and Liver. Clinical Oncology (Royal College of Radiologists) 2020;32:792-804.

13. Eggermont AMM, Blank CU, Mandala M, et al. Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial. Journal of Clinical Oncology 2020;38:3925-36.

14. Gruber E, Franich RL, Shortt J, Johnstone RW, Kats LM. Distinct and overlapping mechanisms of resistance to azacytidine and guadecitabine in acute myeloid leukemia. Leukemia 2020;34:3388-92.

15. Herberts C, Murtha AJ, Fu S, et al. Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer. European Urology 2020;78:834-44.

16. John T, Cooper WA, Wright G, et al. Lung Cancer in Australia. Journal of Thoracic Oncology 2020;15:1809-14.

17. Kater AP, Wu JQ, Kipps T, et al. Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study. Journal of Clinical Oncology 2020;38:4042-54.

18. Koo E, Henderson MA, Dwyer M, Skandarajah AR. Radiation-associated breast cancers in a late-effects cohort: Long-term surveillance is essential. Asia-Pacific Journal of Clinical Oncology 2020;16:363-71.

19. Lee JC, Alipour R, Chong JW. Using D-dimer and Clinical Decision Rules to Improve Pulmonary Embolism Diagnosis and Reduce the Risk of Overtesting. Academic Radiology 2020;27:1791.

20. Lisy K, Kent J, Piper A, Jefford M. Facilitators and barriers to shared primary and specialist cancer care: a systematic review. Supportive Care in Cancer 2021;29:85-96.

21. Lwin Y, Kennedy G, Gottlieb D, et al. Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry. Biology of Blood and Marrow Transplantation 2020;26:2252-61.

22. MacKay SG, Lewis R, McEvoy D, Joosten S, Holt NR. Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association(). Respirology 2020;25:1292-308.

23. Marine JC, Dawson SJ, Dawson MA. Non-genetic mechanisms of therapeutic resistance in cancer. Nature Reviews: Cancer 2020;20:743-56.

24. Marsavela G, Lee J, Calapre L, et al. Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy. Clinical Cancer Research 2020;26:5926-33.

25. Miller RE, Leary A, Scott CL, et al. ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer. Annals of Oncology 2020;31:1606-22.

26. Mir F, Mattiello F, Grigg A, et al. Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy. American Journal of Hematology 2020;95:1503-10.

27. Peffault de Latour R, Brodsky RA, Ortiz S, et al. Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies. British Journal of Haematology 2020;191:476-85.

28. Prabahran AA, Ritchie DS. Poor graft function, a significant and emerging clinical challenge post allogeneic stem cell transplantation. Leukemia and Lymphoma 2020;61:2786-7.

29. Ratnayake CBB, Kamarajah SK, Loveday BPT, et al. A Network Meta-analysis of Surgery for Chronic Pancreatitis: Impact on Pain and Quality of Life. Journal of Gastrointestinal Surgery 2020;24:2865-73.

30. Rojas-Jiménez E, Mejía-Gómez JC, Díaz-Velásquez C, et al. Comprehensive Genomic Profile of Heterogeneous Long Follow-Up Triple-Negative Breast Cancer and Its Clinical Characteristics Shows DNA Repair Deficiency Has Better Prognostic. Genes (Basel) 2020;11.

31. Rose MT, Slavin M, Trubiano J. The democratization of de-labeling: a review of direct oral challenge in adults with low-risk penicillin allergy. Expert Review of Anti-Infective Therapy 2020;18:1143-53.

32. Salmon JM, Bots M, Vidacs E, et al. Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia. Clinical Epigenetics 2020;12:178.

33. Sek K, Kats LM, Darcy PK, Beavis PA. Pharmacological and genetic strategies for targeting adenosine to enhance adoptive T cell therapy of cancer. Current Opinion in Pharmacology 2020;53:91-7.

34. Seth R, Messersmith H, Kaur V, et al. Systemic Therapy for Melanoma: ASCO Guideline. Journal of Clinical Oncology 2020;38:3947-70.

35. Shaw AT, Bauer TM, de Marinis F, et al. First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer. New England Journal of Medicine 2020;383:2018-29.

36. Srijakotre N, Liu HJ, Nobis M, et al. PtdIns(3,4,5)P(3)-dependent Rac exchanger 1 (P-Rex1) promotes mammary tumor initiation and metastasis. Proceedings of the National Academy of Sciences of the United States of America 2020;117:28056-67.

37. Steer B, Loeliger J, Edbrooke L, Deftereos I, Laing E, Kiss N. Malnutrition Prevalence according to the GLIM Criteria in Head and Neck Cancer Patients Undergoing Cancer Treatment. Nutrients 2020;12.

38. Tan L, Solomon BJ. Defining resistance mechanisms to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer. Annals of Oncology 2020;31:1599-600.

39. Tiffen J, Gallagher SJ, Filipp F, et al. EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma. Journal of Investigative Dermatology 2020;140:2442-54.e5.

40. Trubiano JA, Marhoon N, Vogrin S, Chua KYL, Holmes NE. Matched Case-Control Study of the Long-Term Impact of Beta-Lactam Antibiotic Allergy Testing. Antimicrobial Agents and Chemotherapy 2020;64.

41. Trubiano JA, Vogrin S, Kwong JC, Homes N. Alterations in Smell or Taste-Classic Coronavirus Disease 2019? Clinical Infectious Diseases 2020;71:2307-9.

42. Valentine JC, Hall L, Spelman T, et al. Burden and clinical outcomes of hospital-coded infections in patients with cancer: an 11-year longitudinal cohort study at an Australian cancer centre. Supportive Care in Cancer 2020;28:6023-34.

43. Waterhouse NJ, Sedelies KA, Clarke CJ. Granzyme B; the chalk-mark of a cytotoxic lymphocyte. Journal of Translational Medicine 2004;2:36.

44. Wong M, Mayoh C, Lau LMS, et al. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer. Nature Medicine 2020;26:1742-53.

45. Zhao Y, Pan Z, Namburi S, et al. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence. EBioMedicine 2020;61:103030.